Rational design and multi-target computational evaluation of novel nevirapine analogues as dual HIV-1 reverse transcriptase/integrase inhibitors with improved safety profiles
Publication date: 2026 Source: In Silico Research in Biomedicine, Volume 2 Author(s): Md. Limon Khan, Fahad Fardin, Amit Dhar, Md Shohanur Rahman, Salman Reja, MD Fahimul Haque, Md. Al-Amin
Rational design and multi-target computational evaluation of novel nevirapine analogues as dual HIV-1 reverse transcriptase/integrase inhibitors with improved safety profiles. // In Silico Research in Biomedicine. – URL: https://www.sciencedirect.com/science/article/pii/S3050787126005354?dgcid=rss_sd_all
Rational design and multi-target computational evaluation of novel nevirapine analogues as dual HIV-1 reverse transcriptase/integrase inhibitors with improved safety profiles. In Silico Research in Biomedicine. https://www.sciencedirect.com/science/article/pii/S3050787126005354?dgcid=rss_sd_all
“Rational design and multi-target computational evaluation of novel nevirapine analogues as dual HIV-1 reverse transcriptase/integrase inhibitors with improved safety profiles.” In Silico Research in Biomedicine.
@article{article107640,
title = {Rational design and multi-target computational evaluation of novel nevirapine analogues as dual HIV-1 reverse transcriptase/integrase inhibitors with improved safety profiles},
journal = {In Silico Research in Biomedicine},
url = {https://www.sciencedirect.com/science/article/pii/S3050787126005354?dgcid=rss_sd_all}
}
Publication date: November–December 2026 Source: Acta Otorrinolaringologica (English Edition), Volume 77, Issue 6 Author(s): Daniel Álvarez de Castro, Sandra Pérez de la Iglesia, Miguel Ramírez Verdyguer, Francisco José Manzano Gómez